|
WO2013155218A1
|
|
Chirally pure isomers of itraconazole for use as angiogenesis inhibitors
|
|
US2008213782A1
|
|
SOCS-1 gene methylation in cancer
|
|
CA2663521A1
|
|
Combinatorial therapy of cancer and infectious diseases with anti-b7-h1 antibodies
|
|
CA2656807A1
|
|
Early detection and prognosis of colon cancers
|
|
CA2641026A1
|
|
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
|
US2007197638A1
|
|
Weight loss induced by reduction in neuropeptide level
|
|
EP1858533A2
|
|
Use of amniotic fluid (af) in treating ocular disease and injury
|
|
CA2595726A1
|
|
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
|
CA2583110A1
|
|
Polyamine analogs as therapeutic agents for ocular diseases
|
|
US2005216962A1
|
|
Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
|
|
US7371527B1
|
|
Hypermethylation of GATA-4 and GATA-5 transcription factor genes in cancer
|
|
US2005084883A1
|
|
Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differential gene expression analysis
|
|
EP1597749A2
|
|
Tandem time-of-flight mass spectrometer
|
|
WO2004071464A2
|
|
Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells
|
|
NZ539520A
|
|
Biocompatible cross-linked polymer matrices, and methods of making and using same
|
|
WO2004027036A2
|
|
Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
|
|
AU2003259202A8
|
|
Compositions and methods for treating and preventing infection
|
|
AU2003278161A1
|
|
Membrane associated tumor endothelium markers
|
|
EP1997494A2
|
|
Modulators of hedgehog signaling pathways, compositions and uses related thereto
|
|
AU2003228410A8
|
|
Device, systems and methods for heating of a vessel in combination with mr/nmr imaging
|
